Moleculin Biotech • MBRX
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Walter V. Klemp$9.6M
Market Cap • 22/04/20242015
(há 9 anos)
2016
(8 years ago)
NASDAQ
Listagem
Houston
Sede • Texas19
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MBRXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.